Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome

Sleep

Volumn 24, Issue 5, 2001, Pages 545-553

  Nakamura, T ^a,a   Chin, K ^a   Shimizu, K ^a   Kita, H ^a   Mishima, M ^a   Ohi, M ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apnea hypopnea index; CD4 positive T lymphocyte; Immune response; Nasal continuous positive airway pressure; Obstructive sleep apnea syndrome

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MALE; NOSE AIRFLOW; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; T LYMPHOCYTE SUBPOPULATION;

EID: 0035426854     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/24.5.545     Document Type: Article

References (37)

1. Recognition of obstructive sleep apnea
2. Complications of obesity
3. The influence of obesity and its treatment on the immune system
4. Impaired immunity in obesity: Suppressed but reversible lymphocyte responsiveness
5. + T-cell clones
6. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF
7. Leptin regulates proinflammatory immune responses
8. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
9. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines
10. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy
11. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin
12. Obstructive sleep apnea
13. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation
14. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans
15. Effects of sleep and circadian rhythm on human circulating immune cells
16. Differential effects of growth hormone and prolactin on murine T cell development and function
17. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment
18. Growth hormone alters lymphocyte sub-populations and antibody production in dwarf rats in vivo
19. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment
20. Heat shock protein 72 level decreases during sleep in patients with obstructive sleep apnea syndrome
21. Heat shock proteins and the immune response
22. Effects of stress on the immune system
23. Familial primary biliary cirrhosis associated with impaired concanavalin A-induced lymphocyte transformation in relatives. Two family studies
24. Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines
25. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea
26. Hypoxemia vs sleep fragmentation as cause of excessive daytime sleepiness in obstructive sleep apnea
27. Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system
28. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment
29. Beta-adrenergic receptors in human leukocyte sub-populations
30. Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers
31. Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea. Effects of nasal continuous positive airway pressure therapy
32. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure
33. Body fat and the activity of the autonomic nervous system
34. Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart
35. Catecholamines and blood pressure in obstructive sleep apnea syndrome
36. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome